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The rat intervertebral disk degeneration pain
model: relationships between biological and
structural alterations and pain
Jae-Sung Kim1, Jeffrey S Kroin2, Xin Li1, Howard S An3, Asokumar Buvanendran2, Dongyao Yan1,
Kenneth J Tuman2, Andre J van Wijnen4, Di Chen1 and Hee-Jeong Im1,3,5,6*
Abstract
Introduction: Degeneration of the interverterbral disk is as a cause of low-back pain is increasing. To gain insight
into relationships between biological processes, structural alterations and behavioral pain, we created an animal
model in rats.
Methods: Disk degeneration was induced by removal of the nucleus pulposus (NP) from the lumbar disks (L4/L5
and L5/L6) of Sprague Dawley rats using a 0.5-mm-diameter microsurgical drill. The degree of primary hyperalgesia
was assessed by using an algometer to measure pain upon external pressure on injured lumbar disks. Biochemical
and histological assessments and radiographs of injured disks were used for evaluation. We investigated
therapeutic modulation of chronic pain by administering pharmaceutical drugs in this animal model.
Results: After removal of the NP, pressure hyperalgesia developed over the lower back. Nine weeks after surgery
we observed damaged or degenerated disks with proteoglycan loss and narrowing of disk height. These biological
and structural changes in disks were closely related to the sustained pain hyperalgesia. A high dose of morphine
(6.7 mg/kg) resulted in effective pain relief. However, high doses of pregabalin (20 mg/kg), a drug that has been
used for treatment of chronic neuropathic pain, as well as the anti-inflammatory drugs celecoxib (50 mg/kg; a
selective inhibitor of cyclooxygenase 2 (COX-2)) and ketorolac (20 mg/kg; an inhibitor of COX-1 and COX-2), did
not have significant antihyperalgesic effects in our disk injury animal model.
Conclusions: Although similarities in gene expression profiles suggest potential overlap in chronic pain pathways
linked to disk injury or neuropathy, drug-testing results suggest that pain pathways linked to these two chronic
pain conditions are mechanistically distinct. Our findings provide a foundation for future research on new
therapeutic interventions that can lead to improvements in the treatment of patients with back pain due to disk
degeneration.
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Introduction
The intervertebral disk has a unique structure composed
of a tough outer ring, the annulus fibrosus (AF), as well
as a gelatinous inner core, the nucleus pulposus (NP).
Although there are many causes of low-back pain,
symptomatic degeneration of the intervertebral disk is
thought to be the leading cause of chronic discogenic
pain syndrome in the Western world [1]. Despite exten-
sive study of the degenerative process in the interverteb-
ral disk, the exact mechanism of discogenic back pain
has not been elucidated. Many features of discogenic
pain have not yet been explained, including the fact that
only a minority of patients with severe degenerative
changes of the disk are clinically affected by severe,
chronic back pain. Clearly, more information regarding
the pathogenesis of discogenic pain is needed before a
rational biological or pharmacological treatment strategy
for this pervasive disease process can be designed.
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Animal pain models are essential for understanding
the complexities of pain and the development and test-
ing of new therapies. Joint pain is clinically assessed by
observing human movement and reflexes to touch, as
well as by asking patients to report the quality and
intensity of their pain. Pain in animals can be measured
by observing (1) pain-related behaviors, such as vocaliza-
tion of pain or biting, licking or shaking of the affected
limb; and/or (2) responses to thermal or mechanical sti-
muli. The rabbit disk puncture model has been benefi-
cial in the study of biological mechanisms of disk
degeneration and in testing therapeutics for disk regen-
eration. After annulus needle puncture, the rabbit disk
slowly and progressively degenerates [2]. The degenera-
tion can be quantitatively assessed by conventional
radiography, magnetic resonance imaging (MRI), and
histological examination. Nevertheless, rabbits tend to
show minimal pain behavior during disk degeneration in
this model. Typically, when rabbits sense pain, they
limit their activity and fail to thrive. Rabbits do not dis-
play assessable pain behavior; therefore, they are not sui-
table for the study of discogenic back pain.
Because of rats’ sensitive behavioral responses (for
example, vocalization), rat models have been used exten-
sively to study chronic inflammatory and neuropathic
pain in hind limbs and to evaluate the pharmacokinetics
of analgesics [3-5]. Most studies of disk degeneration
have been performed in the rat tail rather than in lum-
bar disks [6,7], in part because of its anatomical accessi-
bility and minimal surgical morbidity. Intervertebral disk
damage in the rat tail may provoke a painful response.
However, unlike spine disks, tail disks are not weight-
bearing, and it is unclear anatomically which neural
structures or components are involved. Thus, it would
be rather difficult to interpret the resulting nociceptive
pathways. A recent study by Olmarker [8] indicates that
a rat model with measurable pain behavior may be sui-
table for studying discogenic back pain. They reported
that disk puncture with a needle (0.4 mm in diameter)
in rats induced measurable pain behavior with increased
grooming and whole-body ("wet dog”) shaking.
In our present study, we sought to establish novel cor-
relations between pain and pathological changes in the
disk structure. We developed an animal model for
chronic discogenic back pain that is amenable to assess-
ment of behavioral hyperalgesia. We examined biological
links between cellular and structural alterations within
disk components and the development of symptomatic
chronic back pain. We also characterized pain modula-
tors associated with symptomatic back pain in the dorsal
root ganglion (DRG) and the spinal cord. Furthermore,
we performed pharmacological tests to explore potential
therapeutic analgesic modulation of chronic back pain.
Materials and methods
Induction of disk degeneration
This study was approved by the Institutional Animal
Care and Use Committee of Rush University Medical
Center. Adult Sprague Dawley rats (250 to 300 g) were
fasted for 24 hours prior to surgery to allow easier
access to the ventral spine. The animals were anesthe-
tized with 1.5% isoflurane in oxygen (1 L/minute),
which was maintained via a mask. The surgery was per-
formed using aseptic techniques. With the animal in the
supine position, the abdominal hair was shaved,
scrubbed with a topical antiseptic solution (chlorhexi-
dine gluconate) and alcohol three times, and the skin
over the lower abdomen was opened with a #15 scalpel
blade. A midline ventral abdominal incision of 1.5 to 2
cm was made, and the abdominal viscera were gently
retracted to allow visualization and access to the spine
and lumbar disk space. The viscera were irrigated with
prewarmed sterile saline solution and covered with
moist, sterile gauze to maintain tissue hydration.
To induce disk degeneration, disks were punctured
with a microsurgical drill (0.5 mm in diameter and 0.25
mm2 area, equivalent to a 25-gauge needle) inserted
into the intervertebral disks (L4/L5 and L5/L6) to a
depth of 2 mm. This was accomplished by using a poly-
ethylene stopper sleeve (BD Intramedic™ Polyethylene
Tubing (Non-Sterile) (PE 50), catalog no. 427411; BD,
Franklin Lakes, NJ, USA) cut 2 mm shorter than the
length of the drill. Muscles were closed with 3-0 silk
suture, and all skin margins were closed with 4-0 nylon
suture. The animals were then taken off anesthesia and
kept warm in a clean cage postsurgery. For two days fol-
lowing surgery, all animals were injected intramuscularly
with buprenorphine 0.1 mg/kg twice daily as a postsur-
gical analgesic. The animals were then monitored to be
certain that there were no serious impairments due to
the surgery. Another group of animals had their disks
punctured with a larger drill (0.8 mm in diameter and
0.64 mm2 area, equivalent to a 21-gauge needle). For
the sham surgery control group, disks were exposed in
the same way as in the experimental group, but with no
puncture (n = 12 in each animal group). Degeneration
of disks was assessed on the basis of the biochemical,
histological and imaging analyses described in the sec-
tions that follow. A neuropathic pain animal model was
generated by using a L5 spinal nerve ligation model [9]
for comparison with tissue protein and RNA levels in
the disk degeneration model.
Animal behavioral tests
Vocalization threshold in applied pressure test
The vocalization threshold based on the force of an
applied force gauge (SMALGO algometer; Bioseb,
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Vitrolles, 13845 France) was measured by pressing the
0.5-cm2 device tip directly on the dorsal skin over the
punctured disks (L4/L5) and comparing this threshold
value with the force threshold applied to the disks (L4/
L5) in the sham surgery control group. The force was
slowly increased 100 g/second until an audible vocaliza-
tion was heard. A cutoff force of 1,000 g was used to
prevent tissue trauma. The tests were carried out in
duplicate, and the mean value was taken as the nocicep-
tive threshold. Postoperative testing was delayed until
one week after surgery to allow the abdominal tissue to
heal. This pain test is clinically relevant, as patients’
pain is tested by mechanical pressure on disks to assess
their degree of back pain [10-12].
Mechanical allodynia
After allowing the rats to become acclimated to a wire
mesh grid covered with a clear plastic cage for 15 min-
utes, a calibrated set of von Frey filaments (Stoelting,
Wood Dale, IL, USA) was applied from below to the
plantar hind paw to determine the 50% force withdrawal
threshold [13]. The filament forces ranged from 0.04 to
15 g, beginning with 2.0 g. The filament was applied to
the skin with enough pressure to buckle and was main-
tained for up to six seconds. A brisk lifting of the foot
was recorded as a positive response. Mechanical allody-
nia thresholds in spondylosis models were measured for
both legs as indicators of secondary hypersensitivity.
The average of the left and right sides was calculated on
the basis of data derived from all leg pain tests [14].
Motor incoordination
Rats were placed on a rotating rod (the rotarod perfor-
mance test) apparatus at 10 rpm, and the latency to fall
time was recorded for coordination and balance capabil-
ity. The maximum cutoff latency was 300 seconds.
Drug treatment
For drug administration experiments beginning at seven
weeks after induction of disk degeneration, the rats were
gently restrained and given 0.5 ml of drug solution
either intraperitoneally (i.p.) or by oral gavage (p.o.).
The drugs tested were a a2δ1 subunit calcium channel
blocker, pregabalin 20 mg/kg p.o. (Pfizer, Piscataway,
NJ, USA); a mixed cyclooxygenase (COX-1 and COX-2)
inhibitor, ketorolac tromethamine 20 mg/kg i.p. (Sigma-
Aldrich, St Louis, MO, USA); a COX-2 selective inhibi-
tor, celecoxib 50 mg/kg p.o. (Pfizer); a μ-opioid agonist,
morphine sulfate 6.7 mg/kg i.p.; and drug vehicle. Each
drug administration was performed at three- to four-day
intervals in the same rats to minimize the number of
rats used while avoiding residual drug effects of prior
treatments. Pressure hyperalgesia was performed at a
maximum of four time points after drug injection to
limit local tissue hypersensitivity due to the repeated
noxious stimulus itself. The drug vehicle for i.p. delivery
was saline (0.9% sodium chloride injection), and the
drug-suspending vehicle ORA-PLUS (Paddock Labora-
tories, Inc, Minneapolis, MN, USA) was used for p.o.
administration. None of drug doses used in this study
caused sedation or motor incoordination in naïve rats.
Sedation in naïve rats was evaluated by measuring spon-
taneous exploratory activity (ambulation and rearing)
with a photobeam activity monitor as previously
described [15]. Briefly, photobeam-generated counts
were recorded during 30 minutes of activity 1 hour after
injection. The morphine injection (6.7 mg/kg) (n = 8)
versus saline injection (n = 8) ambulation counts
(means ± SEM) were saline 566 ± 57 and morphine 571
± 95 (P = 0.961). The rearing ambulation counts were
saline 127 ± 13 and morphine 111 ± 20 (P = 0.505).
Our data suggest no statistical difference in spontaneous
exploratory activity associated with 6.7 mg/kg morphine.
Histological and data analyses
The animals were killed, and each vertebral lumbar
motion segment was dissected aseptically. The tissues
were fixed in 4% paraformaldehyde and decalcified in
ethylenediaminetetraacetic acid solution (changed every
five days). The decalcified disk was cut in the transverse
plane and embedded in paraffin. Serial frontal disk sec-
tions of exactly 5-μm thickness were obtained to pre-
pare slides. Safranin O Fast Green staining was
performed to assess general morphology and loss of pro-
teoglycan in ground cartilage substance. We compared
all harvested disks using the grading scale published by
Masuda et al. [16]. On the Masuda scale, point scores
range from 4 to 12, where normal (Figure 1A (left
panel): Control) is 1 point for each of the following 4
categories (total of 4 points = grade 4): category I = AF,
category II = border between the AF and NP, category
III = cellularity at the NP and category IV = matrix of
the NP. Because each category has a maximum of 3
points, a total score of 12 points (grade 12) represents
severe degeneration (Figure 1A (right panel): Disk
Injury). An unblinded investigator grouped the slides by
animal. These groups were then randomized for grading.
The grading was repeated by an orthopedic histologist
who was blinded to the animal treatments. The two
independent examinations were performed, and the
repeatability of grading on the two occasions was deter-
mined using Cohen’s  statistic using an internet-based
program [17]. P < 0.05 was defined as significant for all
tests [16,18].
Toluidine blue staining was carried out to assess the
general morphology of mast cells (which appear dark
blue) [19]. Immunohistochemistry was performed using
anti-CD11b antibody according to established methods
[20]. In brief, after blocking endogenous peroxidases, tis-
sue sections were incubated overnight with primary rat
Kim et al. Arthritis Research & Therapy 2011, 13:R165
http://arthritis-research.com/content/13/5/R165
Page 3 of 11
anti-mouse CD11b antibody (Cell Signaling Technology,
Danvers, MA, USA) for macrophage binding. The tissue
sections were then incubated with a secondary biotiny-
lated antibody, followed by incubation with a streptavi-
din-horseradish peroxidase conjugate and development
with 0.5 mg/ml diaminobenzidine.
Imaging analyses for intervertebral disk height index
Disk heights were determined using the MX-20 Speci-
men Radiography System (Faxitron Bioptics LLC, Lin-
colnshire, IL, USA). At the end of the experiment
period, excised lumbar spinal motion segments (L4/L5
and L5/L6) were radiographed by placing the spine seg-
ments directly on the X-ray film for five minutes with
the energy for 10 kV. The image was digitized, and the
gross disk heights were evaluated and graded.
Two examiners who were blinded to the treatment inde-
pendently conducted measurements of disk height. Inter-
vertebral disk height was calculated by using modified
versions of previously established methods [16]. The inter-
vertebral disk height index was obtained by averaging
measurements obtained from anterior, middle and poster-
ior portions of the intervertebral disk and dividing the
measurements by the average of adjacent vertebral body
heights (see Figures 2A and 2B). To evaluate changes in
the intervertebral disk height of degenerated disks, those
disk heights were normalized to the measured sham disk
heights (disk height index = degenerative disk height (n =
6)/sham control disk height (n = 6).
Quantitative real-time polymerase chain reaction
Rats with removed NPs or sham controls were killed at
week 9. Bilateral lumbar DRGs and spinal cord levels
L4/L5 and L5/L6 were harvested, and relative mRNA
levels of pain-related genes were analyzed by quantita-
tive real-time PCR (qRT-PCR). Total RNA was isolated
using the TRIzol reagent (Invitrogen, Carlsbad, CA,
USA) according to the instructions provided by the
manufacturer. Reverse transcription (RT) was carried
out with 1 μg of total RNA using the ThermoScript™
RT-PCR System (Invitrogen) for first-strand cDNA
synthesis. For RT-PCR, cDNA was amplified using the
MyiQ2 Two-Color Real-Time PCR Detection System
(Bio-Rad Laboratories, Hercules, CA, USA). A threshold
cycle (Ct) value was obtained from each amplification
curve by using iQ5 Optical System Software provided by
the manufacturer (Bio-Rad Laboratories). Relative
mRNA expression was determined using the ΔΔCt
method as detailed by the manufacturer (Bio-Rad
Laboratories). The primers employed were (forward) 5’-
TCTGTGCCTCAGCCTCTTCTCATT-3’, (reverse) 5’-
TTGGGAACTTCTCCTC CTTGT TGG-3’ for TNF-a
(National Center for Biotechnology Information (NCBI)
accession NM_012675.3); (forward) 5’-GAAGCTGTAG
Figure 1 Axial sections of the L4/L5 lumbar disks showing immunohistochemical staining with Safranin O, toluidine blue (nine weeks
after surgery) and CD11b. (A) Safranin O-stained sections of sham control (left) and disk injury (right). (B) Toluidine blue-stained sections of
sham control (top left) and traumatic disk puncture (top right) (original magnification, ×40). Lower panels show enlargements (original
magnification, ×100) of boxed portions of top left and top right panels. Mast cells are indicated by dark blue staining. (C) CD11b-stained
sections (original magnification, ×40). Immune cells are shown in dark blue staining. AF = annulus fibrosus; NP = nucleus pulposus.
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TATTTGTCACCAAGC-3’ and (reverse) 5’-CTAATG-
TACTTCTGGAC CCATTCCT-3’ for monocyte che-
moattractant protein 1 (MCP-1) (NCBI M_57441.1);
(forward) 5’-TCTGACAAACCTAGAACATGTGGA-3’
and (reverse) 5’-TCACGTAGA AACTGTAAGTCTTT-
GACA-3’ for Toll-like receptor 4 (TLR4) (NCBI acces-
sion NM_019178.1); 5’-AATGAGAGTGAGTCAGG
CAGCCAA-3’ and (reverse) 5’-ATGGACC GCTGC
ATGTTGATAGG A-3’ for a2δ1 (NCBI accession
NM_012919.2); (forward) 5’- AGGGCAGTTGGA-
CAGTCATTGGTA-3’ and (reverse) 5’- TTCAACTCT
CATCCACCTT GGCGA-3’ for brain-derived neuro-
trophic factor (BDNF) (NCBI accession NM_012513);
(forward) 5’-TCTAGTGTCACTGCCCAGAAGAGA-3’
and 5’-GGCACAAAGTTG TCCTTCACCACA-3’ for
calcitonin gene-related protein (CGRP) (NCBI accession
NM_001033956.1); (forward) 5’-TTCCCACCACTGCT-
CAAGATG-3’ and (reverse) 5’-TGGCTGACAGGG
TTGCAA-3’ for galanin (NCBI accession NM_033
237.1); (forward) 5’-AAGCTTAAGTGGGACAACCA-
GAAA-3’ and (reverse) 5’-GTTCTCCTGGGACC-
GAGTCA-3’ for dynorphin (NCBI accession NM_01937
4.3); (forward) 5’-AGATCCAGCCCTG AGACACT-
GATT-3’ and (reverse) 5’-TGGAAGGGTCTTC
AAGCCTTGTTC-3’ for neuropeptide Y (NPY) (NCBI
accession NM_012614.1); (forward) 5’-TGGGCAACG-
TAGTGGTGATA-3’ and (reverse) 5’-CACGGCTGT-
CATGGAGTAGA-3’ for neurokinin 1 (NK-1) (NCBI
accession NM_012667.2); (forward) 5’-TGGTCAGAT
CTCTCACAAAAGG-3’ and (reverse) 5’-
TGCATTGCGCTTCTTTCATA-3’ for substance P
(NCBI accession NM_001124768.1); (forward) 5’-
TGTCACCAACTGGGACGATATGGA-3’ and (reverse)
5’-AGCACAGGGTGCTCCTCA-3’ for b-actin (NCBI
accession NM_031144). The deviations in samples
represent three different donors in three separate
experiments.
Protein extraction and Western blot analysis
Tissue lysates obtained from rat were prepared using
modified radioimmunoprecipitation assay buffer as pre-
viously described. Total protein concentrations of tissue
lysates were determined by using bicinchoninic acid
protein assays (Pierce Biotechnology, Rockford, IL,
USA). Equal amounts of protein were resolved by 10%
SDS-PAGE and transferred onto nitrocellulose mem-
brane for Western blot analyses as described previously.
Immunoreactivity was visualized using the Amersham
Figure 2 Using digitized X-ray images, we analyzed measurements, including the vertebral body height and intervertebral disk
height, with imaging software. (A) Digitized X-ray images of intervertebral disk segments obtained to compare presurgery (naïve), sham
control and drill puncture. (B) Intervertebral disk height was calculated by averaging the measurements obtained from the anterior, middle and
posterior portions of the intervertebral disk and dividing that average by the average adjacent vertebral body height. (C) The disk height index
was measured nine weeks after surgery. The disk height index of disk degeneration (DDD) was significantly decreased compared to sham
control (P < 0.01).
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ECL Western Blotting System (GE Healthcare Bio-
Sciences Corp, Piscataway, NJ, USA).
Statistical analysis
The significance of differences among means of data
derived by radiograph measurements was analyzed by
analysis of variance for repeated measurements, and
Fisher’s protected least significant difference test was
used as a post hoc test. All data are expressed as means
± SEM. Statistical analysis was performed using the Stat-
View version 5.0 software program package (SPSS, Inc,
Chicago, IL, USA). The Cohen’s  value was calculated
by using an internet-based program [17]. P < 0.05 was
defined as statistically significant for all tests. Algometer
pressure threshold measurements and von Frey filament
threshold determinations over the seven-week post-
operative period between the disk injury group and
sham control group were compared using a mixed gen-
eral linear model with repeated measures (SAS statistical
software; SAS Institute Inc, Cary, NC, USA). A step-
down Bonferroni correction was used for multiple com-
parisons. Pressure pain measures after drug injection
were compared among different drugs using a mixed
general linear model with repeated measures. For the
straight leg-raising test, vocalizations were compared
over the seven-week testing period using the Friedman
test with a post hoc Wilcoxon signed-rank test. Mea-
sures were compared between experimental animals and
control animals with the Mann-Whitney U test or the
independent samples t-test.
Results
Disk puncture causes symptomatic chronic back pain
Our previous attempts using a 21-gauge drill (0.8 mm
diameter and 0.64 mm2 area) failed to induce gradual
back pain but instead generated rather traumatic, rapid
development of pressure hyperalgesia compared to the
sham control group within one week (F1,8 = 539, P <
0.001) (Figure 3A). By using a smaller microsurgical drill
(0.5 mm diameter and 0.25 mm2 area, equivalent to 25-
gauge), we were able to induce slower development of
pressure hyperalgesia as measured by the vocalization
threshold in response to applied force upon stimulation
of paravertebral tissues of the L4/L5 disk region com-
pared to the sham control group (F1,10 = 19.8, P =
0.0012) (Figure 3B). Our microsurgical disk drill model
demonstrated robust symptomatic discogenic back pain
sustained for the behavioral pain test period (more than
seven weeks after surgery). There was no secondary
hyperalgesia as measured by the von Frey test for
mechanical allodynia in the hind paws of both disk
injury and sham control animals. Animals with disk drill
puncture showed no pain response in the straight leg-
raising test that is often used to diagnose patients with
nerve compression-induced pain, such as that caused by
herniated disks. The animals showed no change in per-
formance using the rotarod test (data not shown).
Disk degeneration-induced hyperalgesia is associated
with disk narrowing
At the end of the nine weeks after initial surgery, the
lumbar spinal motion segments were dissected and the
gross disk heights were determined on the basis of X-
ray imaging (Figures 2A to 2C). All harvested disks
within a single rat were compared to each other and to
the disks of all other rats. Significant disk space narrow-
ing observed at the site of damaged disks was repre-
sented by approximately 55% reduced disk height
compared to the sham control group (Figure 2C) (P < 0.
01). In an effort to rule out normal changes that occur
with aging and/or altered motion as a result of disk
injury that might affect neighboring disks, we compared
Figure 3 Behavioral pain assessments over a seven-week time period. Pressure hypersensitivity of the lower back was determined by
measurement of the vocalization threshold to an applied force gauge (algometer). (A) Graph showing data derived from animals that
underwent traumatic puncture by a drill (0.8 mm in diameter and 0.64 mm2 area) (n = 12) compared with the sham surgery group (n = 12). *P
< 0.001 versus sham group; †P < 0.001 versus presurgery baseline (time 0). (B) Graph showing data derived from animals punctured with a
smaller drill (0.5 mm in diameter and 0.25 mm2 area) (n = 6) were compared with the sham surgery group (n = 6). *P < 0.05 versus sham group;
†P < 0.001 versus presurgery baseline; ‡P < 0.005 versus presurgery baseline.
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the disks within a single animal (injured versus presur-
gery). Our results demonstrate that the disk heights of
the presurgery group were similar to those of the sham
control group (Figure 2A, naïve versus sham control).
We did not observe significant changes in neighboring
disks (L2/L3 and L3/L4) that might have been affected
by the injured disks (data not shown). The disk height
measurement was repeated twice at three-week intervals
to validate the reproducibility of the disk height index.
The intraobserver error of disk height index measure-
ments was estimated to be minimal (within-group stan-
dard deviation (Sw) = 0.003 and coefficient of variation
= 8.5%). The calculated interobserver error was Sw =
0.003 with a 9.5% coefficient of variation. The intraob-
server reliability based on readings taken at two time
intervals three months apart was  = 0.98, showing
excellent agreement.
Disk puncture-induced hyperalgesia is associated with
morphological changes in disks
Disks were harvested for histological assessments at nine
weeks postsurgery. Morphological changes in disks of
the sham control group (n = 6) and the 25-gauge needle
puncture experimental group (n = 6) were compared in
equivalent sections. We performed semiquantitative his-
tological analyses using a grading system based on Safra-
nin O and toluidine blue staining as described
previously [19]. The control group displayed normal-
looking disks with a Masuda grade of 4 (Figures 1A and
1B (left): Control), an intact AF with a normal pattern
of fibrocartilage lamellas (U-shaped in the posterior
aspect and slightly convex in the anterior aspect), a
well-defined border between the AF and NP, and pre-
served proteoglycan content. In contrast, the experimen-
tal group (Figures 1A and 1B (right): Disk Injury)
revealed severely damaged disks (Masuda grade 12) in
which significant proteoglycan depletion was evident,
most of the contents of the NP were lost and/or the
NPs had collapsed (P < 0.05 by Mann-Whitney U test).
At the nine-week time point, all the specimens had the
maximum Masuda score of 12 points after disk injury.
Importantly, at nine weeks, the vocalization threshold
for force pressure was 410 ± 25 g in the disk puncture
group versus 958 ± 26 g (P < 0.001), indicating a corre-
lation between disk degeneration and sustained pain.
Interestingly, we observed that mast cells (visualized
by intense toluidine blue staining), which are known to
play a critical role in wound healing and inflammatory
responses in connective tissue, were significantly
increased at the site of injury in disks. We further vali-
dated our observation on the basis of immunohisto-
chemical analyses by using an immune cell-specific
antibody, CD11b. Our data demonstrate increased
inflammatory responses at the site of disk injury as
represented by highly increased immune reactivity with
a CD11b antibody (Figure 1C: Control versus Disk
Injury). Our observation of increased immuoreactivity to
CD11b is consistent with all specimen sections with a
maximum score of 12 points after disk injury.
The pain pathways evoked by disk degeneration may
overlap those of neuropathic pain
In neuropathic pain models, a set of pain modulators
are upregulated (↑) or downregulated (↓) in sensory
neurons in DRGs and spinal dorsal horn. These neuro-
pathy molecules include CGRP(↓) [21], substance P(↓)
[22] and BDNF(↑) [23], neuropeptide Y(↑) [24], galanin
(↑) [25] via glial activation, which in turn activates the
TNFa, MCP-1 and TLR4 pathways [26,27]. Similarly,
we found highly stimulated expression of TNFa, MCP-1
and TLR4 in both the DRG (L4/L5) (Figures 4A(a) to
4A(c)) and the spinal dorsal horn (Figures 4B(a) to 4B
(c)) in our animal model after disk degeneration with
symptomatic behavioral chronic back pain. Furthermore,
we observed significant increases in a2δ1 expression, a
subunit of the voltage-gated calcium channel involved in
neuropathic pain pathways, in the spinal dorsal horn of
animals with discogenic pain on both the mRNA level
(P < 0.0011) (Figure 4C(a)) and the protein level (P <
0.05) (Figure 4C(b)). These results suggest that the
chronic pain pathways induced by disk degeneration
may, at least in part, overlap with neuropathic pain. A
comprehensive comparison of gene expression profiles
between neuropathic pain and disk degeneration
induced by NP removal is provided in Table 1
[21-25,28,29].
Pharmacological drug tests for therapeutic modulation of
chronic back pain induced by disk degeneration
Therapeutic modulation of chronic pain using pharmaceu-
tical drugs was investigated in the animal model. Because
we observed that animals with sham abdominal incisions
did not show any hyperalgesia (Figure 1), which suggests
that their pain experience was not due to the abdominal
incision, we selected rats with disk injury (but not sham
animals) for testing with a panel of drugs, including mor-
phine, celecoxib, ketorolac and pregabalin. We included
morphine as a control prototype drug that is effective for
certain types of pain (for example, nociceptive, inflamma-
tory and postoperative pain). The potency of morphine in
reducing primary pressure hyperalgesia may indicate a
nociceptive process due to injury at the disks. Ketorolac
and celecoxib are drugs used for inflammatory pain, but
they are not effective for nociceptive pain (acute). Pregaba-
lin is effective for neuropathic pain but not inflammatory
or nociceptive pain. Pain behavior related to noxious sti-
muli was completely reversed by the administration of
morphine sulfate (6.7 mg/kg) as assessed by vocalization
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threshold measurements using an algometer (F4,10 = 47.3,
P < 0.001). The selective COX-2 inhibitor celecoxib (50
mg/kg), the nonsteroidal anti-inflammatory drug ketorolac
(20 mg/kg) and the drug pregabalin (20 mg/kg) did not
have significant antihyperalgesic effects (Figure 5).
Discussion
The results of this study demonstrate the effects of
puncture-induced intervertebral disk injury degeneration
and pain behavior (pressure hyperalgesia) over a period
of seven weeks in a rat model. The novelty of our ani-
mal model is that we were able to correlate structural
and biochemical changes in intervertebral disk to disk
degeneration-associated chronic back pain assessed by
behavioral changes. In our animal model, the develop-
ment of disk-related hyperalgesia was gradual and
reached a maximum pain threshold four weeks after
disk injury. Fast or slow development of pain symptoms
may depend on the impact of the initial injury. The use
of a larger drill (0.8 mm) resulted in more rapid
Table 1 Altered gene expression in the sensory neurons in dorsal root ganglions in a neuropathic animal model
compared to the traumatic disk injury-initiated chronic discogenic pain model
Tissues Pain
modulator
Neuropathic pain (sciatic nerve ligation)a,
reference
Disk degeneration back pain modelb, relative fold induction (n =
12) (P values)
Dorsal
horn
Dynorphin Upregulated [28] 1.941 ± 0.162 (P < 0.05)
NK-1 Upregulated [29] 2.512 ± 0.521 (P < 0.05)
DRG BDNF Upregulated [23] 1.841 ± 0.312 (P < 0.05)
NPY Upregulated [24] 5.367 ± 0.474 (P < 0.05)
CGRP Downregulated [21] 0.487 ± 0.433 (P < 0.05)
Substance P Downregulated [22] 0.712 ± 0.251 (P < 0.05)
Galanin Upregulated [25] 1.1 ± 0.219 (equal)
BDNF = brain-derived neurotrophic factor; CGRP = calcitonin gene-related peptide; DRG = dorsal root ganglion; NK-1 = neurokinin 1; NPY = neuropeptide Y.
aUpregulated and downregulated expression patterns are relative to sham controls. b25-gauge drilling was performed in 12 mice; data are means ± SEM.
Figure 4 Glial activity-associated gene analyses in rats with traumatic disk puncture-induced disc degeneration (DDD) by qRT-PCR and
immunoblotting. (A) (a) through (c) Dorsal root ganglion. (B) (a) through (c) Spinal dorsal horn. (C) (a) and (b) a2δ1 expression in spinal dorsal
horn. Values are means ± SEM.
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development of behavioral changes compared to a smal-
ler drill (0.5 mm). These behavioral changes may be
comparable to those reported by other groups in which
disk degeneration-associated pain was induced by the
potent immune booster Complete Freund’s Adjuvant
(CFA). In the CFA-injected rats, rapid pain development
was evident within one day after intradisk injection with
CFA [30]. Immediate symptomatic pain caused by CFA-
induced disk degeneration may be due to severe inflam-
matory response in the tissues, whereas disk puncture
injury may generate much milder inflammation. More
importantly, CFA-injected rats developed mechanical
allodynia assessed by von Frey test in the hind paws,
whereas no development of statistically significant sec-
ondary hyperalgesia (mechanical allodynia) was observed
in animals with disk degeneration. It is important to
note that clinically significant mechanical allodynia does
not develop in patients with discogenic back pain
(unpublished observations - Dr. Asokumar
Buvanendran).
In the current study, we generated rat lumbar disk
degeneration by puncturing two consecutive disks (L4/
L5 and L5/L6). The consecutive disk degeneration pro-
cedure provides a model replicating the clinical reality
that patients with symptomatic disk degeneration likely
have multiple disk defects (albeit, presumably, with dif-
ferent degrees of disk degeneration). Our model facili-
tates pain assessments with greater sensitivity (more
vocalization) than single-disk degeneration. Owing to
the relatively small size of the animals (entire lumbar
spinal column only 2 cm in length), we could not assess
the degree of pain for individual lumbar disks. For
example, it is not feasible to examine pain differences
between the L3/L4 and L5/L6 disks. Our gene expres-
sion profiles suggest that chronic back pain may have a
neuropathic component and may be linked to neuro-
pathic pain pathways. The findings of this work corro-
borate the results of other studies of osteoarthritis-
related chronic pain in symptomatic knee joints [19].
Our results obtained with pharmacological drug treat-
ments suggest that the current animal model for disk
degeneration-initiated pain recapitulates responses to
human symptoms. For example, the potency of mor-
phine (a positive control in the drug treatment in our
study) in reducing primary pressure hyperalgesia may
indicate a nociceptive process due to injury at the disks.
The relative ineffectiveness of anti-inflammatory drugs
in our animal model suggests that disk degeneration-
induced chronic back pain might have resulted from a
distinct pain pathway and might differ from other
chronic pain conditions induced by an inflammatory
pain source. Although oral administration of pregabalin
did not attenuate pressure hyperalgesia in the disk
degeneration model, even at the highest dose (20 mg/
kg), our gene expression profiling suggests that disk
degeneration-induced pain mechanisms may, at least in
part, overlap with neuropathic pain mechanisms by sig-
nificantly stimulating a2δ1 calcium subunits at the per-
ipheral and central nervous system in both pain
conditions.
In these studies, we performed a single analgesic
administration for each drug, based on previously pub-
lished studies by our group and others. For example, a
single p.o. dose of pregabalin 10 mg/kg completely
reversed mechanical allodynia in the spinal nerve liga-
tion model (the Chung model [9]) for at least five hours
[31], and a single 3 mg/kg dose of ketorolac completely
abolished pain-related behavior in a postoperative pain
model [15]. Importantly, the doses of celecoxib used in
the current studies were higher than the half-maximal
effective dose (ED50) for reversal of paw pressure hyper-
algesia (ED50 = 4.1 mg/kg/dose) [32]. Thus these drugs
may not be effective in alleviating discogenic pain path-
way, but are effective blockers of other pain symptoms
such as neuropathy or postoperative pain.
Although dosing in humans generally is less than 0.1
mg/kg, none of the drug concentrations used for the
animals in this study caused sedation or motor incoordi-
nation. For example, administration of morphine (6.7
Figure 5 Measurement of the vocalization threshold using a
pressure algometer test to examine the pharmacological
efficacy of drugs on traumatic disk puncture-initiated
discogenic pain (tested during weeks 7 through 9).
Administration of pregabalin (20 mg/kg), morphine (6.7 mg/kg),
celecoxib (selective inhibitor of COX-2, 50 mg/kg), ketorolac (COX-1
and COX-2 inhibitor, 20 mg/kg) or control vehicle by either oral
gavage or intraperitoneal injection followed by primary pressure
pain assessment by algometer. Morphine demonstrated a potent
analgesic drug effect with a single administration, whereas
pregabalin, celecoxib and ketorolac use led to no significant
behavioral changes compared to saline control. *P < 0.001
compared to the other drug groups; †P < 0.001 compared to
presurgery baseline (time 0). COX-1 = cyclooxygenase 1; COX-2 =
cyclooxygenase 2.
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mg/kg) showed dramatic pharmacological antihyperalge-
sic effects without statistical differences in tests that
monitor balance (the rotarod performance test) or spon-
taneous exploratory activity (for example, ambulation
and rearing). These species differences in morphine
drug responses may be due to distinctions in neurologi-
cal parameters and pharmacokinetics. In one of our ear-
lier studies with the most widely used postoperative
pain model in rats (the Brennan model [18]), the ED50
needed to achieve antihyperalgesic effects was 3 mg/kg
morphine, but 1 mg/kg morphine did not show any
analgesic effects in rats [33].
It should be noted that although intervertebral disk
degeneration is quite common and thought to be part of
the aging process, the etiology and source of pain due to
intervertebral disk degeneration is not well understood.
The severity of disk degeneration does not always corre-
late with the degree of pain. Diagnosis of chronic pain
due to disk degeneration is complex and based on multi-
ple criteria, including clinical findings, as well as on
radiographic and MRI and/or invasive discography. The
animals with acute disk injury in our study exhibited
increased behavioral hyperalgesia after surgery that per-
sisted for the entire pain assessment period of seven
weeks. Despite the strengths of our study, it remains
unclear whether the animals would heal from lesser inju-
ries. Furthermore, we have not been able to correlate the
severity of pain with the degree of disk degeneration
assessed by biochemical, histological and imaging ana-
lyses. Future time-course studies designed to correlate
biochemical, histological and structural changes and pain
scores at the early, intermediate and end stages of disk
degeneration within and beyond seven weeks may be
valuable for determination of the etiology of discogenic
pain and pain sources by evaluating alterations in proper-
ties of peripheral disk tissues, disk heights, subchondral
end plates and sensory nerve ingrowth, as well as changes
in pain modulators in the nervous system.
Conclusions
Our findings provide the basis for future research on
new therapeutic interventions that may lead to improve-
ments in the treatment of patients with back pain due
to disk degeneration.
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